Axq Capital, LP Xenon Pharmaceuticals Inc. Transaction History
Axq Capital, LP
- $417 Billion
- Q1 2024
A detailed history of Axq Capital, LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Axq Capital, LP holds 5,662 shares of XENE stock, worth $241,937. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,662
Previous 7,006
19.18%
Holding current value
$241,937
Previous $323 Million
24.46%
% of portfolio
0.06%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
226Shares Held
68.9MCall Options Held
307KPut Options Held
68.9K-
Avoro Capital Advisors LLC New York, NY5.67MShares$242 Million2.94% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.32MShares$185 Million2.04% of portfolio
-
Wellington Management Group LLP Boston, MA3.92MShares$168 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$115 Million0.02% of portfolio
-
Polar Capital Holdings PLC London, X02.61MShares$112 Million0.7% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.66B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...